Gareth Bond

Gareth Bond

University of Oxford

H-index: 30

Europe-United Kingdom

About Gareth Bond

Gareth Bond, With an exceptional h-index of 30 and a recent h-index of 21 (since 2020), a distinguished researcher at University of Oxford, specializes in the field of mdm2, polymorphisms, cyclin, p53.

His recent articles reflect a diverse array of research interests and contributions to the field:

New role of fat-free mass in cancer risk linked with genetic predisposition

Evaluating the Prevalence and Factors Associated With an Optimal Neurodevelopmental Outcome in 4-to 6-Year-Old Children With Fontan Circulation

Neurodevelopmental Outcomes of Infants after Neonatal Surgical Intervention for Tetralogy of Fallot or Pulmonary Atresia

Genomic hallmarks and therapeutic implications of G0 cell cycle arrest in cancer

Corrigendum: MEF2 transcription factors are key regulators of sprouting angiogenesis

A novel map of human p53 response elements uncovers evidence of selection pressures and variants similar to Li-Fraumeni Syndrome mutations

A genetic model for central chondrosarcoma evolution correlates with patient outcome

Optimizing CRISPR/Cas9 editing of repetitive single nucleotide variants

Gareth Bond Information

University

Position

___

Citations(all)

5849

Citations(since 2020)

1524

Cited By

4985

hIndex(all)

30

hIndex(since 2020)

21

i10Index(all)

45

i10Index(since 2020)

33

Email

University Profile Page

Google Scholar

Gareth Bond Skills & Research Interests

mdm2

polymorphisms

cyclin

p53

Top articles of Gareth Bond

New role of fat-free mass in cancer risk linked with genetic predisposition

Scientific reports

2024/3/27

Evaluating the Prevalence and Factors Associated With an Optimal Neurodevelopmental Outcome in 4-to 6-Year-Old Children With Fontan Circulation

Canadian Journal of Cardiology

2023/2/1

Neurodevelopmental Outcomes of Infants after Neonatal Surgical Intervention for Tetralogy of Fallot or Pulmonary Atresia

The Journal of Pediatrics

2023/11/1

Genomic hallmarks and therapeutic implications of G0 cell cycle arrest in cancer

Genome Biology

2023/5/23

Corrigendum: MEF2 transcription factors are key regulators of sprouting angiogenesis

Genes & Development

2022/10/10

A novel map of human p53 response elements uncovers evidence of selection pressures and variants similar to Li-Fraumeni Syndrome mutations

medRxiv

2022/9/29

A genetic model for central chondrosarcoma evolution correlates with patient outcome

Genome medicine

2022/8/30

Optimizing CRISPR/Cas9 editing of repetitive single nucleotide variants

Frontiers in Genome Editing

2022/7/5

Germline pathogenic variants impact clinicopathology of advanced lung cancer

Cancer Epidemiology, Biomarkers & Prevention

2022/7/1

An efficient and adaptable workflow for editing disease-relevant single nucleotide variants using CRISPR/Cas9

bioRxiv

2021/11/12

Heritable genetic variants in key cancer genes link cancer risk with anthropometric traits

Journal of Medical Genetics

2021/6/1

Post‐operative fluid overload as a predictor of hospital and long‐term outcomes in a pediatric heart transplant population

Pediatric Transplantation

2021/5

Germline and somatic genetic variants in the p53 pathway interact to affect cancer risk, progression, and drug response

Cancer Research

2021/4/1

A common polymorphism in the retinoic acid pathway modifies adrenocortical carcinoma age-dependent incidence

British Journal of Cancer

2020/4

Pre‐school neurocognitive and functional outcomes after liver transplant in children with early onset urea cycle disorders, maple syrup urine disease, and propionic acidemia …

JIMD reports

2020/3

Kindergarten‐age neurocognitive, functional, and quality‐of‐life outcomes after liver transplantation at under 6 years of age

Pediatric Transplantation

2020/3

See List of Professors in Gareth Bond University(University of Oxford)